주사 펜 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,302,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,698,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,488,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

주사펜 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 주사 펜 시장 규모는 2030년까지 607억 달러에 달할 것으로 예상되며, 2025-2030년 7.4%의 성장률을 나타낼 것으로 예상됩니다.

다양한 만성 및 급성 질환을 관리하기 위해 이러한 장비에 대한 높은 수요와 신흥 국가 시장에서의 인식 증가가 시장을 주도할 것으로 예상되는 주요 요인입니다.

주사 펜은 간헐적으로 주사를 맞아야 하는 만성질환 관리시 환자의 편의성을 향상시키는 데 큰 성공을 거두었습니다. 이 장비는 다른 전달 시스템보다 편리하고 가격이 저렴하며, C형 간염 및 암을 포함한 다른 질병 관리에 대한 적용을 평가하기 위한 지속적인 연구로 인해 2025년까지 시장이 빠르게 성장할 것으로 예상됩니다.

주사펜 시장 : 분석 개요

• 재사용 부문은 2024년 70.4%의 가장 큰 매출 점유율을 차지하며, 의료 산업의 환경적 지속가능성에 대한 관심이 높아짐에 따라 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 병원 부문은 2024년 39.4%의 최대 매출 점유율로 시장을 장악했습니다. 이는 의료 인프라를 강화하기 위한 정부의 구상이 증가하고 평가 기간 중 당뇨병 환자 인구가 증가함에 따라 빠르게 수용되고 촉진되었기 때문입니다.
• 북미는 2024년 44.7%의 점유율을 차지하며 주사펜 시장을 독점했습니다. 캐나다와 미국과 같은 국가에서 당뇨병, 암, 심혈관 질환, 다발성 경화증과 같은 비 전염성 질환의 발생이 증가하는 것이 시장 성장을 가속하는 주요 요인입니다.

목차

제1장 분석 방법·범위

제2장 개요

제3장 주사 펜 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 주사 펜 시장 : 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 주사 펜 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 주사 펜 시장 : 변동 분석, 제품별
• 주사 펜 시장의 전망 : 제품별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 일회용형
• 재이용형

제5장 주사 펜 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 주사 펜 시장 : 변동 분석, 용도별
• 주사 펜 시장의 전망 : 용도별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 당뇨병
• 아나필락시스
• 골다공증
• 성장호르몬 결핍증
• 관절염
• 기타

제6장 주사 펜 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 주사 펜 시장 : 변동 분석, 최종 용도별
• 주사 펜 시장의 전망 : 최종 용도별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 병원
• 진료소
• 재택 의료

제7장 주사 펜 시장 : 지역별 추정·동향 분석

• 지역별 대시보드
• 주사 펜 시장 : 변동 분석, 지역별
• 주사 펜 시장 : 지역별 추정·동향 분석, 기술별·유저빌리티별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 시장 참여 기업의 분류
• 주요 기업 개요
  • BD
  • Eli Lilly and Company
  • Ypsomed AG
  • Biocon
  • Pfizer Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Sanofi
  • Owen Mumford Ltd.
  • Merck KGaA

KSA

영문 목차

영문목차

Injection Pen Market Growth & Trends:

The global injection pen market size is expected to reach USD 60.7 billion by 2030, according to a new report by Grand View Research, Inc., registering a 7.4% from 2025 to 2030. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.

Injectable pens have witnessed significant success in improving patient convenience during management of chronic disease, a process that might include administering intermittent injections. These devices are more convenient and affordable than other delivery systems. Ongoing studies on the same to assess their applications in management of other diseases, including but not limited to Hepatitis C and cancer, is expected to ensure swift market growth through 2025.

Injection Pen Market Report Highlights:

• The reusable segment accounted for the largest revenue share of 70.4% in 2024 and is expected to grow at the fastest CAGR over the forecast period due to the growing focus on environmental sustainability in the healthcare industry.
• The hospital segment dominated the market with the largest revenue share of 39.4% in 2024, due to the quick acceptance and boost from the rise in government efforts to enhance healthcare infrastructure and the increasing population of diabetes patients within the evaluated timeframe.
• North America dominated the injection pen market and accounted for a 44.7% share in 2024. The rising occurrence of non-communicable diseases, such as diabetes, cancer, cardiovascular conditions, and multiple sclerosis in countries like Canada and the U.S. is a major factor driving the growth of the market.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Injection Pen Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Injection Pen Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Injection Pen Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Injection Pen Market: Product Movement Analysis
• 4.3. Injection Pen Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Disposable
  • 4.5.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Reusable
  • 4.6.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Injection Pen Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Injection Pen Market: Application Movement Analysis
• 5.3. Injection Pen Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Diabetes
  • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Anaphylaxis
  • 5.6.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Osteoporosis
  • 5.7.1. Osteoporosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Growth Hormone Deficiency
  • 5.8.1. Growth Hormone Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Arthritis
  • 5.9.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Injection Pen Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Injection Pen Market: End Use Movement Analysis
• 6.3. Injection Pen Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospital
  • 6.5.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Clinics
  • 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Home Care Settings
  • 6.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Injection Pen Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Injection Pen Market movement analysis
• 7.3. Injection Pen Market: Regional Estimates & Trend Analysis by Technology & Usability
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. BD
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Type benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Eli Lilly and Company
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Type benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Ypsomed AG
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Type benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Biocon
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Type benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Pfizer Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Type benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Novartis AG
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Type benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Novo Nordisk A/S
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Type benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Sanofi
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Type benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Owen Mumford Ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Type benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Merck KGaA
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Type benchmarking
    • 8.2.10.4. Strategic initiatives

관련자료